tiprankstipranks
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
Holding DNTH?
Track your performance easily

Dianthus Therapeutics (DNTH) Stock Investors

302 Followers
Based on 770,014 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DNTH
On average, investors allocate 0.00% of their portfolios to DNTH
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 770,014 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DNTH

4.3%
Last 7
Days
0.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DNTH, out of 770,014 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DNTH Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,717 investors who made their portfolios public
The table shows changes in DNTH in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DNTH Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.49%
-0.36%
+4.91%
5.79B
Healthcare
Bristol-Myers Squibb
3.56%
-2.05%
-1.78%
119.22B
Healthcare
DraftKings
5.44%
-2.59%
-1.15%
37.87B
Consumer Cyclical
Plug Power
5.22%
-3.09%
-3.30%
2.00B
Industrials
JD
5.00%
-1.83%
+2.18%
54.96B
Consumer Cyclical
Enphase Energy
4.58%
-2.00%
-1.96%
9.72B
Technology
Devon Energy
4.61%
-3.08%
-2.18%
25.14B
Energy
Block
4.39%
-2.32%
+1.22%
56.25B
Technology
XPeng, Inc. ADR
5.50%
-3.28%
-3.68%
10.97B
Consumer Cyclical
Carnival
6.33%
-0.35%
+8.78%
31.54B
Consumer Cyclical
Based on the activity of 770,014 active portfolios
Open your Smart Portfolio

DNTH Investor Analysis

DNTH investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.9%
of DNTH holders
are under 35
Average Segment Performance
Average P/E Ratio29.30
Beta10.71
Dividend Yield195.35%
DNTH investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
48.8%
of DNTH holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.56
Beta20.58
Dividend Yield89.27%
DNTH investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
46.3%
of DNTH holders
are over 55
Average Segment Performance
Average P/E Ratio25.04
Beta9.37
Dividend Yield151.42%
Overview of age group and performance of DNTH stock investors
See who invests in DNTH according to age group and performance.

FAQ

How many retail Investors hold DNTH?
<0.1% of TipRanks' retail investors hold DNTH in their portfolios.
    What is DNTH Investor Sentiment?
    DNTH’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DNTH in the last 7 days?
      ▼ 4.3% of TipRanks' retail investors changed their holding of DNTH in the last 7 days.
        What percentage of retail investors changed their holding of DNTH in the last 30 days?
        ▼ 0.9% of TipRanks' retail investors changed their holding of DNTH in the last 30 days.
          What is the average age of retail investors who hold DNTH?
          The average age of DNTH Holders is between 35–55.
            What other stocks have DNTH investors also bought?
            DNTH Investors also bought VKTX, BMY, DKNG, PLUG, JD, ENPH, DVN, SQ, XPEV, CCL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CRMDCormedix
              GERNGeron
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis